Comment
doi: 10.1056/NEJM200005183422017.
Patients 65 years of age or older in cancer-treatment trials
- PMID: 10819657
- DOI: 10.1056/NEJM200005183422017
Item in Clipboard
Comment
Patients 65 years of age or older in cancer-treatment trials
N Engl J Med.
.
Free article
No abstract available
Comment on
-
Underrepresentation of patients 65 years of age or older in cancer-treatment trials.N Engl J Med. 1999 Dec 30;341(27):2061-7. doi: 10.1056/NEJM199912303412706. N Engl J Med. 1999. PMID: 10615079
Similar articles
-
Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier?J Clin Oncol. 2003 Apr 15;21(8):1618-23. doi: 10.1200/JCO.2003.12.044. J Clin Oncol. 2003. PMID: 12697888
-
Patients 65 years of age or older in cancer-treatment trials.N Engl J Med. 2000 May 18;342(20):1531. N Engl J Med. 2000. PMID: 10819658 No abstract available.
-
Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration.J Clin Oncol. 2004 Nov 15;22(22):4626-31. doi: 10.1200/JCO.2004.02.175. J Clin Oncol. 2004. PMID: 15542812
-
The challenges of clinical trials for adolescents and young adults with cancer.Pediatr Blood Cancer. 2008 May;50(5 Suppl):1101-4. doi: 10.1002/pbc.21459. Pediatr Blood Cancer. 2008. PMID: 18360838 Review.
-
Breast cancer in older women.Semin Oncol. 1996 Feb;23(1 Suppl 2):82-8. Semin Oncol. 1996. PMID: 8614851 Review.
Cited by
-
Inflammation-based markers can predict the prognosis of geriatric patients with metastatic colorectal cancer receiving first-line chemotherapy.Transl Cancer Res. 2019 Aug;8(4):1137-1147. doi: 10.21037/tcr.2019.06.27. Transl Cancer Res. 2019. PMID: 35116856 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
